Literature DB >> 28507453

Erratum to: Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells.

Hongyu Jing1,2, Lucy Liaw1, Robert Friesel1, Calvin Vary1, Shucheng Hua2, Xuehui Yang1.   

Abstract

[This corrects the article DOI: 10.1186/s12935-016-0292-7.].

Entities:  

Year:  2017        PMID: 28507453      PMCID: PMC5427597          DOI: 10.1186/s12935-017-0423-9

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


Erratum to: Cancer Cell Int (2016) 16:19 DOI 10.1186/s12935-016-0292-7

Upon publication of the original article [1], it was noted that the Core Facilities utilized by the authors for their research were not adequately acknowledged in the manuscript. In this case, the following was mistakenly omitted: Progenitor cell analysis core Molecular Phenotyping core Stem Cell COBRE Grant P30GM106391 Vascular Biology COBRE Grant P30GM103392 This has since been acknowledged and corrected in this erratum.
  1 in total

1.  Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells.

Authors:  Hongyu Jing; Lucy Liaw; Robert Friesel; Calvin Vary; Shucheng Hua; Xuehui Yang
Journal:  Cancer Cell Int       Date:  2016-03-11       Impact factor: 5.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.